Flomax

Tykerb® plus Femara® Improves Quality-adjusted Survival in Women with HER2+ Metastatic Breast Cancer

Tuesday, October 13th, 2009

Researchers affiliated with a large Phase III international randomized trial have reported that Tykerb® (lapatinib) and Femara® (letrozole) improves quality-adjusted survival (Q-TWIST) compared with Femara alone in women with metastatic HER2+ breast cancer. The details of this study were presented at the 2009 ASCO Breast Cancer Symposium in San Francisco, October 8-10.[1]
Tykerb, an oral tyrosine [...]

New, Cheaper Generic Drugs Become Available This Year

Friday, January 23rd, 2009

Generic drugs are just as effective and safe as their brand-name counterparts because they’re virtually the same — except for the price, of course. Here’s what you should know.
Copied Drugs
Approved by the U.S. Food and Drug Administration (FDA), generic drugs contain the same active ingredients, dosage and quality as their brand-name counterparts.
The only differences between them [...]